1. Home
  2. MDGL vs OS Comparison

MDGL vs OS Comparison

Compare MDGL & OS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • OS
  • Stock Information
  • Founded
  • MDGL 2011
  • OS 2012
  • Country
  • MDGL United States
  • OS United States
  • Employees
  • MDGL N/A
  • OS N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • OS
  • Sector
  • MDGL Health Care
  • OS
  • Exchange
  • MDGL Nasdaq
  • OS NYSE
  • Market Cap
  • MDGL 6.8B
  • OS 6.7B
  • IPO Year
  • MDGL N/A
  • OS 2024
  • Fundamental
  • Price
  • MDGL $295.36
  • OS $27.70
  • Analyst Decision
  • MDGL Strong Buy
  • OS Strong Buy
  • Analyst Count
  • MDGL 10
  • OS 21
  • Target Price
  • MDGL $420.63
  • OS $32.10
  • AVG Volume (30 Days)
  • MDGL 374.9K
  • OS 1.1M
  • Earning Date
  • MDGL 05-01-2025
  • OS 05-08-2025
  • Dividend Yield
  • MDGL N/A
  • OS N/A
  • EPS Growth
  • MDGL N/A
  • OS N/A
  • EPS
  • MDGL N/A
  • OS N/A
  • Revenue
  • MDGL $317,383,000.00
  • OS $515,424,999.00
  • Revenue This Year
  • MDGL $264.55
  • OS $22.64
  • Revenue Next Year
  • MDGL $67.21
  • OS $20.29
  • P/E Ratio
  • MDGL N/A
  • OS N/A
  • Revenue Growth
  • MDGL N/A
  • OS 26.83
  • 52 Week Low
  • MDGL $200.08
  • OS $16.69
  • 52 Week High
  • MDGL $377.46
  • OS $35.39
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.64
  • OS N/A
  • Support Level
  • MDGL $287.46
  • OS N/A
  • Resistance Level
  • MDGL $307.54
  • OS N/A
  • Average True Range (ATR)
  • MDGL 16.74
  • OS 0.00
  • MACD
  • MDGL -2.04
  • OS 0.00
  • Stochastic Oscillator
  • MDGL 12.84
  • OS 0.00

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About OS ONESTREAM INC

OneStream Inc is an AI-enabled and extensible software platform that unifies core financial functions and broader operational data and processes within a single platform. The Digital Finance Cloud of the company provides a comprehensive, dynamic, and predictive view of the entire enterprise, providing corporate leaders the control, visibility, and agility required to proactively adjust business and day-to-day execution.

Share on Social Networks: